224 related articles for article (PubMed ID: 10686032)
1. Evaluation of the antibody specificities of human convalescent-phase sera against the attachment (G) protein of human respiratory syncytial virus: influence of strain variation and carbohydrate side chains.
Palomo C; Cane PA; Melero JA
J Med Virol; 2000 Apr; 60(4):468-74. PubMed ID: 10686032
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the human serological immune response to a variable region of the attachment (G) protein of respiratory syncytial virus during primary infection.
Cane PA; Thomas HM; Simpson AF; Evans JE; Hart CA; Pringle CR
J Med Virol; 1996 Mar; 48(3):253-61. PubMed ID: 8801286
[TBL] [Abstract][Full Text] [Related]
3. Induction of protective immunity in rodents by vaccination with a prokaryotically expressed recombinant fusion protein containing a respiratory syncytial virus G protein fragment.
Power UF; Plotnicky-Gilquin H; Huss T; Robert A; Trudel M; Ståhl S; Uhlén M; Nguyen TN; Binz H
Virology; 1997 Apr; 230(2):155-66. PubMed ID: 9143271
[TBL] [Abstract][Full Text] [Related]
4. Host cell effect upon glycosylation and antigenicity of human respiratory syncytial virus G glycoprotein.
García-Beato R; Martínez I; Francí C; Real FX; García-Barreno B; Melero JA
Virology; 1996 Jul; 221(2):301-9. PubMed ID: 8661440
[TBL] [Abstract][Full Text] [Related]
5. Detection of human respiratory syncytial virus genotype specific antibody responses in infants.
McGill A; Greensill J; Marsh R; Craft AW; Toms GL
J Med Virol; 2004 Nov; 74(3):492-8. PubMed ID: 15368511
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the binding of monoclonal and polyclonal antibodies to the glycoproteins of antigenic variants of human respiratory syncytial virus by surface plasmon resonance.
McGill A; Marsh R; Craft AW; Toms GL
J Immunol Methods; 2005 Feb; 297(1-2):143-52. PubMed ID: 15777938
[TBL] [Abstract][Full Text] [Related]
7. Increased susceptibility of human respiratory syncytial virus to neutralization by anti-fusion protein antibodies on adaptation to replication in cell culture.
Marsh R; Connor A; Gias E; Toms GL
J Med Virol; 2007 Jun; 79(6):829-37. PubMed ID: 17457900
[TBL] [Abstract][Full Text] [Related]
8. Antigenic analysis of chimeric and truncated G proteins of respiratory syncytial virus.
Sullender W
Virology; 1995 May; 209(1):70-9. PubMed ID: 7747486
[TBL] [Abstract][Full Text] [Related]
9. [Plasmid construction, expression, immunogenicity and protective efficacy of recombinant protein candidate vaccine of respiratory syncytial virus].
Zeng RH; Gong W; Fang XP; Zhang ZY; Mei XG
Sheng Wu Gong Cheng Xue Bao; 2005 Jul; 21(4):534-9. PubMed ID: 16176088
[TBL] [Abstract][Full Text] [Related]
10. Immune responses to the nonglycosylated ectodomain of respiratory syncytial virus attachment glycoprotein mediate pulmonary eosinophilia in inbred strains of mice with different MHC haplotypes.
Hancock GE; Tebbey PW; Scheuer CA; Pryharski KS; Heers KM; LaPierre NA
J Med Virol; 2003 Jun; 70(2):301-8. PubMed ID: 12696122
[TBL] [Abstract][Full Text] [Related]
11. The immune response of small children by antibodies of different classes to respiratory syncytial virus (RSV) proteins.
Wilczyński J; Lukasik B; Torbicka E; Tranda I; Brzozowska-Binda A
Acta Microbiol Pol; 1994; 43(3-4):369-79. PubMed ID: 7740987
[TBL] [Abstract][Full Text] [Related]
12. The humoral immune response of children and infants to an RSV infection: its maturation and association with illness.
Forster J; Streckert HJ; Werchau H
Klin Padiatr; 1995; 207(6):313-6. PubMed ID: 8569131
[TBL] [Abstract][Full Text] [Related]
13. Antigenic structure of the human respiratory syncytial virus G glycoprotein and relevance of hypermutation events for the generation of antigenic variants.
Martínez I; Dopazo J; Melero JA
J Gen Virol; 1997 Oct; 78 ( Pt 10)():2419-29. PubMed ID: 9349460
[TBL] [Abstract][Full Text] [Related]
14. Serum antibody response to respiratory syncytial virus F and N proteins in two populations at high risk of infection: children and elderly.
Sastre P; Cusi MG; Manoha C; Schildgen O; Ruiz T; Vela C; Rueda P
J Virol Methods; 2010 Sep; 168(1-2):170-6. PubMed ID: 20488207
[TBL] [Abstract][Full Text] [Related]
15. Conformational constraints of conserved neutralizing epitopes from a major antigenic area of human respiratory syncytial virus fusion glycoprotein.
López JA; Andreu D; Carreño C; Whyte P; Taylor G; Melero JA
J Gen Virol; 1993 Dec; 74 ( Pt 12)():2567-77. PubMed ID: 7506298
[TBL] [Abstract][Full Text] [Related]
16. The G protein of human respiratory syncytial virus: significance of carbohydrate side-chains and the C-terminal end to its antigenicity.
Palomo C; García-Barreno B; Peñas C; Melero JA
J Gen Virol; 1991 Mar; 72 ( Pt 3)():669-75. PubMed ID: 2005433
[TBL] [Abstract][Full Text] [Related]
17. Antigenic and immunogenic analysis of group A and group B respiratory syncytial virus G proteins expressed from recombinant baculoviruses.
Sullender WM; Britt WJ
J Gen Virol; 1996 Apr; 77 ( Pt 4)():641-8. PubMed ID: 8627252
[TBL] [Abstract][Full Text] [Related]
18. Mapping of monoclonal antibody epitopes of the human respiratory syncytial virus p protein.
García J; García-Barreno B; Martinez I; Melero JA
Virology; 1993 Jul; 195(1):239-42. PubMed ID: 7686311
[TBL] [Abstract][Full Text] [Related]
19. Identification of multiple protective epitopes (protectopes) in the central conserved domain of a prototype human respiratory syncytial virus G protein.
Plotnicky-Gilquin H; Goetsch L; Huss T; Champion T; Beck A; Haeuw JF; Nguyen TN; Bonnefoy JY; Corvaïa N; Power UF
J Virol; 1999 Jul; 73(7):5637-45. PubMed ID: 10364313
[TBL] [Abstract][Full Text] [Related]
20. Comparison of antibodies directed against human respiratory syncytial virus antigens present in two commercial preparations of human immunoglobulins with different neutralizing activities.
Sastre P; Melero JA; García-Barreno B; Palomo C
Vaccine; 2004 Dec; 23(4):435-43. PubMed ID: 15530691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
